Tandem Diabetes Care, Inc. (TNDM)
USD 17.66
(-6.51%)
USD 17.66
(-6.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 600.92 Million USD | 9.98% |
| 2022 | 474.79 Million USD | 34.29% |
| 2021 | 353.56 Million USD | 31.69% |
| 2020 | 268.47 Million USD | 27.28% |
| 2019 | 210.93 Million USD | 56.88% |
| 2018 | 134.45 Million USD | 25.61% |
| 2017 | 107.03 Million USD | 5.31% |
| 2016 | 101.64 Million USD | 6.34% |
| 2015 | 95.58 Million USD | 5.14% |
| 2014 | 90.91 Million USD | 63.51% |
| 2013 | 55.6 Million USD | 75.4% |
| 2012 | 31.69 Million USD | 30.93% |
| 2011 | 24.21 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 143.56 Million USD | 5.29% |
| 2024 Q1 | 136.35 Million USD | 6.23% |
| 2023 Q3 | 121.29 Million USD | -13.69% |
| 2023 Q1 | 131.97 Million USD | -0.98% |
| 2023 FY | 522.17 Million USD | 9.98% |
| 2023 Q4 | 128.35 Million USD | 5.82% |
| 2023 Q2 | 140.54 Million USD | 6.49% |
| 2022 Q2 | 114.18 Million USD | 7.29% |
| 2022 Q4 | 133.27 Million USD | -12.27% |
| 2022 FY | 474.79 Million USD | 34.29% |
| 2022 Q1 | 106.43 Million USD | 5.39% |
| 2022 Q3 | 151.91 Million USD | 33.05% |
| 2021 Q4 | 100.99 Million USD | 13.44% |
| 2021 Q3 | 89.02 Million USD | 2.3% |
| 2021 Q1 | 76.52 Million USD | 6.44% |
| 2021 Q2 | 87.02 Million USD | 13.72% |
| 2021 FY | 353.56 Million USD | 31.69% |
| 2020 Q4 | 71.89 Million USD | 8.4% |
| 2020 FY | 268.47 Million USD | 27.28% |
| 2020 Q3 | 66.32 Million USD | -0.16% |
| 2020 Q2 | 66.42 Million USD | 4.06% |
| 2020 Q1 | 63.83 Million USD | 9.82% |
| 2019 Q4 | 58.12 Million USD | 2.54% |
| 2019 FY | 210.93 Million USD | 56.88% |
| 2019 Q1 | 44.35 Million USD | 8.24% |
| 2019 Q2 | 51.76 Million USD | 16.73% |
| 2019 Q3 | 56.68 Million USD | 9.5% |
| 2018 Q3 | 37.5 Million USD | 28.95% |
| 2018 Q2 | 29.08 Million USD | 8.16% |
| 2018 Q1 | 26.88 Million USD | -0.6% |
| 2018 FY | 134.45 Million USD | 25.61% |
| 2018 Q4 | 40.97 Million USD | 9.25% |
| 2017 Q2 | 26.97 Million USD | -3.61% |
| 2017 Q1 | 27.97 Million USD | 19.51% |
| 2017 FY | 107.03 Million USD | 5.31% |
| 2017 Q4 | 27.05 Million USD | 8.03% |
| 2017 Q3 | 25.03 Million USD | -7.16% |
| 2016 Q1 | 26.16 Million USD | 6.03% |
| 2016 FY | 101.64 Million USD | 6.34% |
| 2016 Q2 | 25.22 Million USD | -3.58% |
| 2016 Q4 | 23.41 Million USD | -12.77% |
| 2016 Q3 | 26.83 Million USD | 6.37% |
| 2015 Q2 | 23.47 Million USD | 1.09% |
| 2015 FY | 95.58 Million USD | 5.14% |
| 2015 Q3 | 24.21 Million USD | 3.17% |
| 2015 Q1 | 23.21 Million USD | -3.42% |
| 2015 Q4 | 24.67 Million USD | 1.91% |
| 2014 Q2 | 21.76 Million USD | 0.29% |
| 2014 FY | 90.91 Million USD | 63.51% |
| 2014 Q4 | 24.03 Million USD | 2.72% |
| 2014 Q3 | 23.4 Million USD | 7.51% |
| 2014 Q1 | 21.7 Million USD | 22.97% |
| 2013 Q3 | 14.66 Million USD | 4.1% |
| 2013 Q2 | 14.08 Million USD | 52.97% |
| 2013 Q1 | 9.2 Million USD | 15.76% |
| 2013 FY | 55.6 Million USD | 75.4% |
| 2013 Q4 | 17.65 Million USD | 20.4% |
| 2012 Q4 | 7.95 Million USD | -7.23% |
| 2012 Q3 | 8.57 Million USD | 0.0% |
| 2012 FY | 31.69 Million USD | 30.93% |
| 2011 FY | 24.21 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -5253.885% |
| Cerus Corporation | 143.15 Million USD | -319.769% |
| OrthoPediatrics Corp. | 137.01 Million USD | -338.567% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -5189.386% |
| Talis Biomedical Corporation | 67.18 Million USD | -794.413% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -2308.883% |
| Inogen, Inc. | 236.08 Million USD | -154.535% |
| Spectral AI, Inc. | 20.86 Million USD | -2780.176% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -973.129% |
| CVRx, Inc. | 76.14 Million USD | -689.21% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -16932.899% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -4711.594% |
| Orthofix Medical Inc. | 667.42 Million USD | 9.965% |
| Venus Concept Inc. | 80.47 Million USD | -646.707% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -962.109% |
| Bioventus Inc. | 409.91 Million USD | -46.595% |
| BrainsWay Ltd. | 28.01 Million USD | -2044.764% |
| Envoy Medical, Inc. | 17.89 Million USD | -3257.47% |
| electroCore, Inc. | 32.03 Million USD | -1776.058% |
| IceCure Medical Ltd | 16.87 Million USD | -3460.796% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -1316.195% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -3307.923% |
| MaxCyte, Inc. | 84.84 Million USD | -608.256% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -4741.535% |
| Nexalin Technology, Inc. | 5.78 Million USD | -10294.101% |
| PAVmed Inc | 64.82 Million USD | -826.959% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -1076.475% |
| RxSight, Inc. | 103.85 Million USD | -478.642% |
| Sight Sciences, Inc. | 126.44 Million USD | -375.227% |
| SI-BONE, Inc. | 156.35 Million USD | -284.34% |
| TELA Bio, Inc. | 84.18 Million USD | -613.792% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -757.771% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -195.488% |
| LivaNova PLC | 843.54 Million USD | 28.763% |
| 908 Devices Inc. | 68.08 Million USD | -782.667% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -24.26% |
| Nemaura Medical Inc. | 7.13 Million USD | -8317.658% |
| NeuroPace, Inc. | 75.29 Million USD | -698.077% |
| LENSAR, Inc. | 33.33 Million USD | -1702.616% |
| Apyx Medical Corporation | 51.01 Million USD | -1077.859% |
| Cutera, Inc. | 197.72 Million USD | -203.919% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -2324.922% |
| BioSig Technologies, Inc. | 28.53 Million USD | -2006.274% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -213.837% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -1566.445% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 28.153% |
| Axonics, Inc. | 270.2 Million USD | -122.397% |
| Outset Medical, Inc. | 198.77 Million USD | -202.319% |
| IRIDEX Corporation | 31.81 Million USD | -1788.854% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -233.439% |
| IRadimed Corporation | 30.12 Million USD | -1894.9% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -6943.132% |
| INVO Bioscience, Inc. | 7.85 Million USD | -7551.822% |
| Telesis Bio, Inc. | 63.48 Million USD | -846.495% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -510.362% |
| Varex Imaging Corporation | 224.8 Million USD | -167.313% |
| Quipt Home Medical Corp. | 148.66 Million USD | -304.205% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5025.992% |
| Pulmonx Corporation | 112.68 Million USD | -433.265% |
| Dynatronics Corporation | 9.9 Million USD | -5964.982% |
| Modular Medical, Inc. | 17.52 Million USD | -3328.148% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -2876.767% |
| Semler Scientific, Inc. | 38.94 Million USD | -1443.036% |
| InMode Ltd. | 215.68 Million USD | -178.616% |
| Bruker Corporation | 1.07 Billion USD | 44.173% |
| Cytosorbents Corporation | 48.33 Million USD | -1143.192% |
| DexCom, Inc. | 1.69 Billion USD | 64.468% |
| Align Technology, Inc. | 2.07 Billion USD | 71.065% |
| Viveve Medical, Inc. | 22.17 Million USD | -2610.143% |
| ZimVie Inc. | 275.12 Million USD | -118.416% |
| Movano Inc. | 29.69 Million USD | -1923.981% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -337.762% |
| Nexalin Technology, Inc. | 5.78 Million USD | -10294.101% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -16932.899% |
| Profound Medical Corp. | 33.6 Million USD | -1688.285% |
| Insulet Corporation | 939.9 Million USD | 36.066% |
| enVVeno Medical Corporation | 25.23 Million USD | -2281.013% |
| Surmodics, Inc. | 98.69 Million USD | -508.853% |
| iCAD, Inc. | 22.22 Million USD | -2603.802% |
| Nuwellis, Inc. | 22.61 Million USD | -2557.409% |
| Biotricity, Inc. | 17.18 Million USD | -3396.862% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -34.769% |
| Aethlon Medical, Inc. | 12.27 Million USD | -4794.477% |
| InspireMD, Inc. | 22.95 Million USD | -2518.388% |
| PAVmed Inc. | 64.82 Million USD | -826.959% |
| BIOLASE, Inc. | 34.66 Million USD | -1633.706% |
| Beyond Air, Inc. | 61.7 Million USD | -873.938% |
| FONAR Corporation | 28.6 Million USD | -2000.775% |
| AxoGen, Inc. | 149.33 Million USD | -302.395% |
| Vivani Medical, Inc. | 26.96 Million USD | -2128.518% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -239.326% |
| Inari Medical, Inc. | 448.59 Million USD | -33.956% |
| UFP Technologies, Inc. | 58.08 Million USD | -934.482% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -12094.986% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -9410.803% |
| Tenon Medical, Inc. | 16.96 Million USD | -3441.49% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -8028.229% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -1262.542% |
| AdaptHealth Corp. | 1.07 Billion USD | 44.254% |
| Sintx Technologies, Inc. | 15.2 Million USD | -3853.161% |
| NanoVibronix, Inc. | 4.97 Million USD | -11983.652% |
| Quanterix Corporation | 118.1 Million USD | -408.823% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5025.992% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -4060.92% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -53.036% |
| TransMedics Group, Inc. | 182.82 Million USD | -228.695% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -2041.172% |
| NeuroMetrix, Inc. | 11.09 Million USD | -5314.214% |
| Hyperfine, Inc. | 52.87 Million USD | -1036.556% |
| Establishment Labs Holdings Inc. | 172 Million USD | -249.366% |
| Biomerica, Inc. | 6.97 Million USD | -8511.637% |
| Bone Biologics Corporation | 9.42 Million USD | -6273.575% |
| AVITA Medical, Inc. | 80.77 Million USD | -643.904% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -5727.829% |
| Silk Road Medical, Inc | 186.35 Million USD | -222.456% |